Orchestra BioMed (OBIO) News Today $2.71 +0.11 (+4.23%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.70 -0.01 (-0.41%) As of 08/8/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Brokerages Set Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Target Price at $14.00August 9 at 2:25 AM | americanbankingnews.comOrchestra BioMed rises as trial for antihypertensive drug expandsAugust 8 at 2:19 PM | msn.comOrchestra BioMed's (OBIO) Buy Rating Reiterated at Chardan CapitalAugust 8 at 10:11 AM | marketbeat.comOrchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient EligibilityAugust 8 at 7:00 AM | globenewswire.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of "Buy" by AnalystsAugust 6 at 2:20 AM | marketbeat.comDavid P. Hochman Purchases 20,000 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) StockAugust 5, 2025 | marketbeat.comOrchestra BioMed (OBIO) Projected to Post Earnings on MondayAugust 5, 2025 | marketbeat.comOrchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity OfferingsAugust 5, 2025 | globenewswire.comInsider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Acquires 20,000 Shares of StockAugust 5, 2025 | insidertrades.comOrchestra BioMed Secures $70 Million in Strategic Investments to Advance Cardiology PipelineAugust 3, 2025 | msn.comOrchestra BioMed Holdings, Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded WarrantsAugust 1, 2025 | quiverquant.comQOrchestra BioMed Announces Pricing of $40 Million Public OfferingAugust 1, 2025 | globenewswire.comLigand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMedJuly 31, 2025 | finance.yahoo.comOrchestra BioMed Announces Proposed Public OfferingJuly 31, 2025 | globenewswire.comIFP Advisors Inc Acquires 83,481 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO)July 25, 2025 | marketbeat.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of "Buy" by BrokeragesJuly 12, 2025 | marketbeat.comOrchestra BioMed (NASDAQ:OBIO) Trading Up 1.7% - Here's What HappenedJuly 10, 2025 | marketbeat.comHedge funds owners may take dramatic actions as Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) recent 14% drop adds to one-year lossesJuly 2, 2025 | finance.yahoo.comOrchestra BioMed Confirms Director Elections and AuditorJune 24, 2025 | tipranks.comOrchestra BioMed Highlights Potential of AVIM Therapy for Managing Hypertension in High-Risk Patients at CSI 2025 MeetingJune 20, 2025 | nasdaq.comOrchestra BioMed Highlights AVIM Therapy’s Potential at CSI 2025 MeetingJune 18, 2025 | msn.comOrchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025June 18, 2025 | globenewswire.comOrchestra BioMed: Two Best-In-Class Devices And Promising PartnershipsMay 28, 2025 | seekingalpha.comOrchestra BioMed (NASDAQ:OBIO) Announces Quarterly Earnings ResultsMay 14, 2025 | marketbeat.comOrchestra BioMed Holdings - Breakthrough Device Designation Gives Speculative OptimismMay 14, 2025 | seekingalpha.comOrchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical MilestonesMay 12, 2025 | globenewswire.comOrchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough DesignationMay 11, 2025 | msn.comOrchestra BioMed Expands Patent Portfolio with 10 New Patents for Hypertension Treatment, Totaling 120 Global PatentsMay 9, 2025 | nasdaq.comOrchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart FailureMay 8, 2025 | finance.yahoo.comBarclays Has Lowered Expectations for Orchestra BioMed (NASDAQ:OBIO) Stock PriceMay 7, 2025 | marketbeat.comOrchestra BioMed's AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart FailureMay 7, 2025 | globenewswire.comBoxer Capital Management LLC Makes New $953,000 Investment in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO)May 4, 2025 | marketbeat.comOrchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR TreatmentMay 1, 2025 | msn.comOrchestra BioMed to Present at Jefferies Global Healthcare ConferenceMay 1, 2025 | msn.comFDA approves head-to-head trial of Orchestra BioMed’s balloonApril 30, 2025 | investing.comOrchestra BioMed (NASDAQ:OBIO) Shares Down 6.1% - Time to Sell?April 30, 2025 | marketbeat.comOrchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated BalloonApril 29, 2025 | globenewswire.comOrchestra BioMed to Participate in Upcoming Institutional Investor ConferencesApril 28, 2025 | globenewswire.comOrchestra BioMed (NASDAQ:OBIO) Given Buy Rating at Chardan CapitalApril 24, 2025 | marketbeat.comOrchestra BioMed to Highlight Advancements in Cardiac Therapy at HRS 2025April 24, 2025 | msn.comOrchestra BioMed announces AVIM therapy-focused satellite symposium at HRS 2025April 23, 2025 | markets.businessinsider.comOrchestra BioMed granted breakthrough device designation, says H.C. WainwrightApril 23, 2025 | markets.businessinsider.comOrchestra BioMed Secures FDA Breakthrough Device Designation for AVIM TherapyApril 23, 2025 | msn.comOrchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual MeetingApril 23, 2025 | globenewswire.comOrchestra BioMed shares surge on FDA breakthrough designationApril 22, 2025 | in.investing.comOrchestra BioMed Receives FDA Breakthrough Device Designation for AVIM TherapyApril 22, 2025 | globenewswire.comWhat is B. Riley's Estimate for OBIO Q1 Earnings?April 8, 2025 | marketbeat.comChardan Capital Has Strong Outlook for OBIO FY2025 EarningsApril 8, 2025 | marketbeat.comOrchestra BioMed (NASDAQ:OBIO) Upgraded by B. Riley to "Strong-Buy" RatingApril 7, 2025 | marketbeat.comOrchestra BioMed (NASDAQ:OBIO) Given New $12.00 Price Target at HC WainwrightApril 6, 2025 | marketbeat.com Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address OBIO Media Mentions By Week OBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OBIO News Sentiment▼0.660.50▲Average Medical News Sentiment OBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OBIO Articles This Week▼122▲OBIO Articles Average Week Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DCTH News Today TMCI News Today BFLY News Today RXST News Today SNWV News Today CATX News Today CLPT News Today NNOX News Today NPCE News Today TCMD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OBIO) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OBIO Stock Alerts